Eradication of Acute Myeloid Leukemia Is Enhanced By Combined Bcl-2 and Mcl-1 Targeting

被引：2
|
作者：
Teh, Tse-Chieh [1 ]
Nguyen, Nhu-Y [2 ]
Glaser, Stefan [3 ]
Moujalled, Donia [2 ]
Pomilio, Giovanna [2 ]
Huang, David C. S. [3 ]
Guthridge, Mark [2 ]
Wei, Andrew H. [2 ,4 ]
机构：
[1] Monash Univ, Alfred Hosp, Melbourne, Vic 3181, Australia
[2] Monash Univ, Melbourne, Vic 3181, Australia
[3] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia
[4] Alfred Hosp, Melbourne, Vic, Australia
来源：
BLOOD | 2014年 / 124卷 / 21期
关键词：
D O I：
10.1182/blood.V124.21.988.988
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Calaspargase-Pegol-Mknl Combined with BCL-2 and MCL-1 Inhibition for Acute Myeloid Leukemia
    Bollino, Dominique
    Ma, Xinrong
    Tighe, Kayla M.
    Casildo, Andrea
    Richard, Katharina
    Passaniti, Antonino
    Carter-Cooper, Brandon
    Strovel, Erin T.
    Emadi, Ashkan
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (23)
  • [2] Individualized Mitochondrial Functional Approach to Combination of BCL-2 and MCL-1 Antagonism in Acute Myeloid Leukemia
    Bhatt, Shruti
    Pioso, Marissa
    Olesinski, Elyse Ann
    Yilma, Binyam
    Buon, Leutz
    Adamia, Sophia
    Zhu, Holly
    Ryan, Jeremy
    Wang, Youzhen
    Erick, Morris
    Halilovic, Ensar
    Weinstock, David M.
    Garcia, Jacqueline S.
    Letai, Anthony
    BLOOD, 2019, 134
  • [3] Targeting MCL-1 and BCL-2: a 1-2 punch
    Brown, Jennifer R.
    BLOOD, 2021, 137 (20) : 2711 - 2712
  • [4] Targeting MCL-1 dysregulates cell metabolism and leukemia-stroma interactions and re-sensitizes acute myeloid leukemia to BCL-2 inhibition
    Carter, Bing Z.
    Mak, Po Yee
    Tao, Wenjing
    Warmoes, Marc
    Lorenzi, Philip L.
    Mak, Duncan
    Ruvolo, Vivian
    Tan, Lin
    Cidado, Justin
    Drew, Lisa
    Andreeff, Michael
    HAEMATOLOGICA, 2022, 107 (01) : 58 - 76
  • [5] Targeting Bcl-2 Proteins in Acute Myeloid Leukemia
    Wei, Yunxiong
    Cao, Yaqing
    Sun, Rui
    Cheng, Lin
    Xiong, Xia
    Jin, Xin
    He, Xiaoyuan
    Lu, Wenyi
    Zhao, Mingfeng
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [6] Targeting Bcl-2 in acute myeloid leukemia cells.
    Simms-Waldrip, T
    Hernandez, J
    Shankar, D
    Moore, TB
    Sakamoto, KM
    JOURNAL OF INVESTIGATIVE MEDICINE, 2006, 54 (01) : S105 - S105
  • [7] Targeting MCL-1/BCL-XL Forestalls the Acquisition of Resistance to ABT-199 in Acute Myeloid Leukemia
    Kevin H. Lin
    Peter S. Winter
    Abigail Xie
    Cullen Roth
    Colin A. Martz
    Elizabeth M. Stein
    Gray R. Anderson
    Jennifer P. Tingley
    Kris C. Wood
    Scientific Reports, 6
  • [8] Targeting MCL-1/BCL-XL Forestalls the Acquisition of Resistance to ABT-199 in Acute Myeloid Leukemia
    Lin, Kevin H.
    Winter, Peter S.
    Xie, Abigail
    Roth, Cullen
    Martz, Colin A.
    Stein, Elizabeth M.
    Anderson, Grace R.
    Tingley, Jennifer P.
    Wood, Kris C.
    SCIENTIFIC REPORTS, 2016, 6
  • [9] Synergistic Activity of Combined Targeting of BCL-2 with MCL-1 or BCL-Xl in B-Cell Precursor All
    Seyfried, F.
    Stirnweiss, F.
    Niedermayer, A.
    Enzenmuller, S.
    Horl, R.
    Kohrer, S.
    Debatin, K. -M.
    Meyer, L.
    PEDIATRIC BLOOD & CANCER, 2021, 68 : S161 - S161
  • [10] Synergistic Action of MCL-1 Inhibitor with BCL-2/BCL-XL or MAPK Pathway Inhibitors Enhances Acute Myeloid Leukemia Cell Apoptosis and Differentiation
    Opydo, Malgorzata
    Mlyczynska, Anna
    Mlyczynska, Ewa
    Rak, Agnieszka
    Kolaczkowska, Elzbieta
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (08)
12345